Momenta Pharma (MNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 382,515 | 248,334 | 76,063 | 150,738 | 61,461 |
| Marketable Securities | 139,129 | 174,076 | 269,017 | 202,413 | 288,583 |
| Receivables | 8,013 | 11,371 | 15,048 | 70,242 | 21,185 |
| Other current assets | 0 | 1,324 | 0 | 0 | 0 |
| TOTAL | $539,127 | $441,423 | $366,926 | $428,000 | $374,708 |
| Non-Current Assets | |||||
| PPE Net | 11,499 | 20,944 | 29,916 | 20,847 | 21,896 |
| Investments And Advances | 23,466 | 27,001 | 37,222 | 0 | 0 |
| Intangibles | 1,730 | 2,883 | 4,036 | 5,189 | 3,528 |
| Other Non-Current Assets | 42,543 | 39,312 | 21,331 | 23,701 | 20,908 |
| TOTAL | $79,238 | $90,140 | $92,505 | $49,737 | $46,332 |
| Total Assets | $618,365 | $531,563 | $459,431 | $477,737 | $421,040 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,263 | 14,073 | 20,714 | 36,527 | 4,053 |
| Accrued Expenses | 58,833 | 17,295 | 20,528 | 26,866 | 24,499 |
| Other current liabilities | 28,113 | 16,227 | 379 | 11 | 460 |
| TOTAL | $106,104 | $51,511 | $44,487 | $70,676 | $38,782 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 895 | 3,916 | 2,866 | 7,272 | 9,770 |
| Other Non-Current Liabilities | 56,861 | 17,270 | 10,039 | 3,793 | 69 |
| TOTAL | $57,801 | $19,044 | $40,790 | $35,153 | $12,282 |
| Total Liabilities | $163,905 | $70,555 | $85,277 | $105,829 | $51,064 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 117,276 | 98,509 | 76,858 | 71,853 | 69,145 |
| Common Shares | 12 | 10 | 8 | N/A | 7 |
| Retained earnings | -1,033,881 | -743,826 | -562,254 | -473,375 | -452,372 |
| Other shareholders' equity | 182 | -201 | -254 | -21 | -44 |
| TOTAL | $454,460 | $461,008 | $374,154 | $371,908 | $369,976 |
| Total Liabilities And Equity | $618,365 | $531,563 | $459,431 | $477,737 | $421,040 |